Frontiers in Psychiatry (Nov 2021)
Changes in Cannabis Consumption During the Global COVID-19 Lockdown: The International COVISTRESS Study
- Juliette Salles,
- Antoine Yrondi,
- Fouad Marhar,
- Nicolas Andant,
- Raimundo Avilés Dorlhiac,
- Binh Quach,
- Jiao Jiao,
- Samuel Antunes,
- Ukadike Chris Ugbolue,
- Julien Guegan,
- Karine Rouffiac,
- Bruno Pereira,
- The COVISTRESS Network,
- Nicolas Andant,
- Maélys Clinchamps,
- Stéphanie Mestres,
- Cécile Miele,
- Valentin Navel,
- Lénise Parreira,
- Bruno Pereira,
- Karine Rouffiac,
- Yves Boirie Jean-Baptiste Bouillon-Minois,
- Martine Duclos Maria Livia Fantini,
- Jeannot Schmidt,
- Stéphanie Tubert-Jeannin,
- Mickael Berthon,
- Pierre Chausse,
- Michael Dambrun,
- Sylvie Droit-Volet,
- Julien Guegan,
- Serge Guimond,
- Laurie Mondillon,
- Armelle Nugier,
- Pascal Huguet,
- Samuel Dewavrin,
- Fouad Marhar,
- Geraldine Naughton,
- Amanda Benson,
- Claus Lamm,
- Karen Gbaglo,
- Vicky Drapeau,
- Raimundo Avilés Dorlhiac,
- Benjamin Bustos,
- Gu Yaodong,
- Haifeng Zhang,
- Peter Dieckmann,
- Julien Baker,
- Binh Quach,
- Jiao Jiao,
- Yanping Duan,
- Gemma Gao,
- Wendy Y J Huang,
- Ka Lai Kelly Lau,
- Chun-Qing Zhang,
- Perluigi Cocco,
- Rosamaria Lecca,
- Monica Puligheddu,
- Michela Figorilli,
- Morteza Charkhabi,
- Reza Bagheri,
- Daniela Pfabigan,
- Peter Dieckmann,
- Samuel Antunes,
- David Neto,
- Pedro Almeida,
- Maria João Gouveia,
- Pedro Quinteiro,
- Constanta Urzeala,
- Benoit Dubuis,
- Juliette Lemaignen,
- Andy Liu,
- Foued Saadaoui,
- Ukadike Chris Ugbolue,
- Keri Kulik,
- Kuan-chou Chen
Affiliations
- Juliette Salles
- University Hospital of Toulouse, CHU Toulouse, Department of Psychiatry, Infinity (Toulouse Institute for Infectious and Inflammatory Diseases), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse, France
- Antoine Yrondi
- University Hospital of Toulouse, CHU Toulouse, Department of Psychiatry, Inserm Toulouse NeuroImaging Center, ToNIC, Toulouse, France
- Fouad Marhar
- Université Clermont Auvergne, CNRS, LaPSCo, Physiological and Psychosocial Stress F-63000 Clermont-Ferrand, France University Hospital of Toulouse, Department of Anaesthesiology and Critical Care, Toulouse, France
- Nicolas Andant
- University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, DRCI, Biostatistics Unit, Clermont-Ferrand, France
- Raimundo Avilés Dorlhiac
- Universidad Finis-Terrae, El-Carmen, Hospital Dr. Luis-Valentìn-Ferrada, Obstetrics and Gynecology, Maipù, Chile
- Binh Quach
- Sport and Physical Education, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China
- Jiao Jiao
- Sport and Physical Education, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China
- Samuel Antunes
- Ordem dos Psicólogos Portugueses, ISPA-Instituto Universitário, Lisbon, Portugal
- Ukadike Chris Ugbolue
- University of the West of Scotland, Institute for Clinical Exercise & Health Science, School of Health and Life Sciences, Glasgow, United Kingdom
- Julien Guegan
- Université Clermont Auvergne, CNRS, LaPSCo, Catech, Clermont-Ferrand, France
- Karine Rouffiac
- 0University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Preventive and Occupational Medicine, Clermont-Ferrand, France
- Bruno Pereira
- University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, DRCI, Biostatistics Unit, Clermont-Ferrand, France
- The COVISTRESS Network
- Nicolas Andant
- Maélys Clinchamps
- Stéphanie Mestres
- Cécile Miele
- Valentin Navel
- Lénise Parreira
- Bruno Pereira
- Karine Rouffiac
- Yves Boirie Jean-Baptiste Bouillon-Minois
- Martine Duclos Maria Livia Fantini
- Jeannot Schmidt
- Stéphanie Tubert-Jeannin
- Mickael Berthon
- Pierre Chausse
- Michael Dambrun
- Sylvie Droit-Volet
- Julien Guegan
- Serge Guimond
- Laurie Mondillon
- Armelle Nugier
- Pascal Huguet
- Samuel Dewavrin
- Fouad Marhar
- Geraldine Naughton
- Amanda Benson
- Claus Lamm
- Karen Gbaglo
- Vicky Drapeau
- Raimundo Avilés Dorlhiac
- Benjamin Bustos
- Gu Yaodong
- Haifeng Zhang
- Peter Dieckmann
- Julien Baker
- Binh Quach
- Jiao Jiao
- Yanping Duan
- Gemma Gao
- Wendy Y J Huang
- Ka Lai Kelly Lau
- Chun-Qing Zhang
- Perluigi Cocco
- Rosamaria Lecca
- Monica Puligheddu
- Michela Figorilli
- Morteza Charkhabi
- Reza Bagheri
- Daniela Pfabigan
- Peter Dieckmann
- Samuel Antunes
- David Neto
- Pedro Almeida
- Maria João Gouveia
- Pedro Quinteiro
- Constanta Urzeala
- Benoit Dubuis
- Juliette Lemaignen
- Andy Liu
- Foued Saadaoui
- Ukadike Chris Ugbolue
- Keri Kulik
- Kuan-chou Chen
- DOI
- https://doi.org/10.3389/fpsyt.2021.689634
- Journal volume & issue
-
Vol. 12
Abstract
Introduction: COVID-19 lockdown measures have been sources of both potential stress and possible psychological and addiction complications. A lack of activity and isolation during lockdown are among the factors thought to be behind the growth in the use of psychoactive substances and worsening addictive behaviors. Previous studies on the pandemic have attested to an increase in alcohol consumption during lockdowns. Likewise, data suggest there has also been a rise in the use of cannabis, although it is unclear how this is affected by external factors. Our study used quantitative data collected from an international population to evaluate changes in cannabis consumption during the lockdown period between March and October, 2020. We also compared users and non-users of the drug in relation to: (1) socio-demographic differences, (2) emotional experiences, and (3) the information available and the degree of approval of lockdown measures.Methods: An online self-report questionnaire concerning the lockdown was widely disseminated around the globe. Data was collected on sociodemographics and how the rules imposed had influenced the use of cannabis and concerns about health, the economic impact of the measures and the approach taken by government(s).Results: One hundred eighty two respondents consumed cannabis before the lockdown vs. 199 thereafter. The mean cannabis consumption fell from 13 joints per week pre-lockdown to 9.75 after it (p < 0.001). Forty-nine respondents stopped using cannabis at all and 66 admitted to starting to do so. The cannabis users were: less satisfied with government measures; less worried about their health; more concerned about the impact of COVID-19 on the economy and their career; and more frightened of becoming infected in public areas. The risk factors for cannabis use were: age (OR = 0.96); concern for physical health (OR = 0.98); tobacco (OR = 1.1) and alcohol consumption during lockdown (OR = 1.1); the pre-lockdown anger level (OR = 1.01); and feelings of boredom during the restrictions (OR = 1.1).Conclusion: In a specific sub-population, the COVID-19 lockdown brought about either an end to the consumption of cannabis or new use of the drug. The main risk factors for cannabis use were: a lower age, co-addictions and high levels of emotions.
Keywords